VEGFA and age-related macular degeneration: A heatmap of the total score of normalized RI for 39 drugs to six subnetworks in AMD and five subnetworks in DR were performed, revealing that the score of anti-VEGF agents, a clinical drug for AMD and DR with high-level evidence, were superior to any other drugs with middle or low-level evidence (Figure 2C).